What is the most recent earnings date for INDV stock?
INDIVIOR PHARMACEUTICALS INC (INDV) last reported earnings on 2/26/2026.
INDIVIOR PHARMACEUTICALS INC (INDV) Earnings History & Surprises
NASDAQ:INDV • US45579U1097
Current stock price
30.26 USD
-0.27 (-0.88%)
Last:
INDV Earnings overview
Past quarterly earnings results for INDIVIOR PHARMACEUTICALS INC (INDV), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- Apr 22, 2026
- Period
- Q1 / 2026
- EPS Estimate
- $0.66
- Revenue Estimate
- 278.09M
Last Reported
Most Recent- Release Date
- Feb 26, 2026
- Period
- Q4 / 2025
- EPS Reported
- $0.82
- EPS Surprise
- 19.28%
- Revenue Surprise
- 14.84%
Beat Rate
Last 8 Quarters 69%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 0.82 | 0.69 | 19.28% | 156.25% | 358M | 311.73M | 14.84% | 20.13% |
| Q3 2025 | 0.72 | 0.42 | 71.47% | 33.33% | 314M | 267.16M | 17.53% | 2.28% |
| Q2 2025 | 0.51 | 0.27 | 92.31% | 164.56% | 302M | 249.39M | 21.10% | 1.00% |
| Q1 2025 | 0.41 | 0.24 | 72.27% | 10.81% | 266M | 244.94M | 8.60% | -6.34% |
| Q4 2024 | 0.32 | 0.22 | 45.92% | -25.58% | 298M | 264.49M | 12.67% | 1.71% |
| Q3 2024 | 0.54 | 0.32 | 70.78% | 58.82% | 307M | 308.86M | -0.60% | 13.28% |
| Q2 2024 | -0.79 | 0.41 | -293.63% | -302.56% | 299M | 307.68M | -2.82% | 8.33% |
| Q1 2024 | 0.37 | 0.42 | -12.59% | - | 284M | 305.75M | -7.11% | 12.25% |
| Q4 2023 | 0.43 | 0.29 | 50.56% | - | 293M | 265.2M | 10.48% | 21.58% |
| Q3 2023 | 0.34 | 0.31 | 11.11% | - | 271M | 270.3M | 0.26% | 16.81% |
| Q2 2023 | 0.39 | - | - | 276M | - | 24.89% | ||
| Q1 2023 | - | - | 253M | - | 22.22% | |||
| Q4 2022 | - | - | 241M | - | 8.07% | |||
| Q3 2022 | - | - | 232M | - | 24.06% | |||
| Q2 2022 | - | - | 221M | - | 9.95% | |||
| Q1 2022 | - | - | 207M | - | 15.00% | |||
| Q4 2021 | - | - | 223M | - | 20.54% | |||
| Q3 2021 | - | - | 187M | - | 17.61% | |||
| Q2 2021 | - | - | 201M | - | 34.00% | |||
| Q1 2021 | - | - | 180M | - | 17.65% | |||
| Q4 2020 | - | - | 185M | - | - | |||
| Q3 2020 | - | - | 159M | - | - | |||
| Q2 2020 | - | - | 150M | - | - | |||
| Q1 2020 | - | - | 153M | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
4
Average EPS beat (4)
70.49%
Max EPS beat (4)
92.31%
Min EPS beat (4)
45.92%
Revenue beat statistics
Revenue beat (4)
4
Average Revenue beat (4)
14.97%
Max Revenue beat (4)
21.10%
Min Revenue beat (4)
8.60%
Analysis
In the last 4 quarters, INDV has consistently beaten EPS estimates in all releases
INDV has consistently beaten revenue estimates in all past 4 earnings releases
In the last 4 quarters, INDV has beaten the EPS estimates by 70.5% on average.
In the last 4 quarters, INDV has beaten the revenue estimates by 15.0% on average.
Related analysis
INDIVIOR PHARMACEUTICALS INC / INDV Earnings FAQ
Did INDIVIOR PHARMACEUTICALS INC (INDV) beat earnings estimates last quarter?
INDIVIOR PHARMACEUTICALS INC (INDV) beat EPS estimates and beat revenue estimates in the most recent quarter.
What percentage of the time does INDV stock beat earnings estimates?
In the last 4 quarters, INDIVIOR PHARMACEUTICALS INC (INDV) has beaten EPS estimates in 4 out of 4 releases.